Timo Ilari Veromaa
Chairman chez HERANTIS PHARMA OYJ
Profil
Timo Ilari Veromaa is currently the Chairman at Herantis Pharma Oyj since 2020.
He is also a Director at Kemianteollisuus ry, Laurantis Pharma Oy, and Biotie Therapies International Oy.
Previously, he served as the President & Chief Executive Officer at Biotie Therapies Oy from 2005 to 2016.
He was also the Chief Executive Officer & Director at Domainex Ltd.
from 2017 to 2018.
Additionally, he held the position of Chairman at Suomen Bioteollisuus ry from 2012 to 2018.
Dr. Veromaa has a doctorate degree from the University of Turku.
Postes actifs de Timo Ilari Veromaa
| Sociétés | Poste | Début |
|---|---|---|
| HERANTIS PHARMA OYJ | Chairman | 01/04/2020 |
| Kemianteollisuus ry | Director/Board Member | - |
| Biotie Therapies International Oy | Director/Board Member | 01/01/2003 |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Director/Board Member | 01/06/2014 |
Anciens postes connus de Timo Ilari Veromaa
| Sociétés | Poste | Fin |
|---|---|---|
Domainex Ltd.
 Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Chief Executive Officer | - |
| Suomen Bioteollisuus ry | Chairman | 01/01/2018 |
| BIOTIE THERAPIES CORP | Chief Executive Officer | 30/06/2016 |
Hermo Pharma Oy
 Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | Director/Board Member | 13/05/2014 |
| Schering Oy | Corporate Officer/Principal | 01/01/1998 |
Formation de Timo Ilari Veromaa
| University of Turku | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HERANTIS PHARMA OYJ | Health Technology |
| Entreprise privées | 9 |
|---|---|
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
| Collagen Corp. | Health Technology |
Domainex Ltd.
Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
| Schering Oy | |
| Suomen Bioteollisuus ry | |
| Kemianteollisuus ry | |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Health Technology |
| Biotie Therapies International Oy |
